Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$4.52−0.33 (-6.80%)
Close on Nov 17, 2026Market cap $284.05MP/E –Yield –
Cytosorbents price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cytosorbents's price to book ratio was 206.4× on Jul 31, 2026, against 73.1× a year earlier. Over the last 5 years it ranged from 24.9× to 280.7×, with a median of 72.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 206.4× | +117.4 |
| 2025 | Dec 31, 2025 | 89.0× | +14.9 |
| 2024 | Dec 31, 2024 | 74.1× | +22.4 |
| 2023 | Dec 29, 2023 | 51.8× | +17.2 |
| 2022 | Dec 30, 2022 | 34.6× | −17.0 |
| 2021 | Dec 31, 2021 | 51.6× | −34.2 |
| 2020 | Dec 31, 2020 | 85.8× | −285.0 |
| 2019 | Dec 31, 2019 | 370.7× | +116.0 |
| 2018 | Dec 31, 2018 | 254.7× | −136.1 |
| 2017 | Dec 29, 2017 | 390.8× | −6.7 |
| 2016 | Jul 29, 2016 | 397.5× | +97.7 |
| 2015 | Dec 31, 2015 | 299.8× | −62.8 |
| 2013 | Jan 31, 2013 | 362.6× | −95.1 |
| 2012 | Dec 31, 2012 | 457.6× | −34.1 |
| 2011 | Dec 30, 2011 | 491.8× | – |
See a number that looks wrong?